Smart innovations like organs-on-a-chip and virtual humans take our science to the next level, while reducing or replacing animal testing. In Utrecht we work on animal-free innovations.
Yoanie Sautjeau is an entrepreneurial student at the ľ¹Ï¸£ÀûÓ°ÊÓ College Utrecht. Here she is sharing her volunteering experience at the 2024 event ChangeNOW in Paris.
Researchers from Utrecht ľ¹Ï¸£ÀûÓ°ÊÓ and UMC Utrecht have received a grant of 936,587 euros from the ZonMw, for research into a serious heart condition that affects both humans and dogs.
On 19 April 2024, Catherine Blanchard addressed equity considerations in relation to environmental issues, human rights and social dimensions of deep-seabed mining
Researchers will train AI-models to identify publications relevant to the IMPROVE project, which seeks to improve how healthcare utilizes patient-generated health data.
A promising immunotherapy for rheumatoid arthritis is proving successful in mouse models. Rheumatoid arthritis has so far had no effective treatment. This research is a step in the right direction.
Students from the School of Law have won the preliminary national round and will take part in the international round of this public international law competition in May
Patients with rheumatoid arthritis all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers unveiled the complexity of these antibodies using powerful lab tools and challenge current therapeutic approaches.
Verticai specializes in pioneering software solutions, based on speech recognition and AI language models, designed to significantly reduce the administrative responsibilities confronting healthcare providers.
Over 330 participants listened to inspiring speakers and attended interactive workshops on navigating social transitions through interdisciplinary education and research.
Two PhD Candidates from Utrecht ľ¹Ï¸£ÀûÓ°ÊÓ, Clara Colonna (Agri-food Law) and Sara Ramezani (Urban Planning), embarked on a unique learning journey in Montpellier, south France.
Psychiatric patients facing severe depression have the option of choosing electroconvulsive therapy (ECT). However, determining which patients will benefit from this intensive treatment can be challenging.
